© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Julie M. Vose, MD, MBA, discusses the importance of conducting genetic testing on all patients with diffuse large B-cell lymphoma to better understand their disease and treat the disease properly.
Julie M. Vose, MD, MBA, professor of internal medicine and chief of the division of oncology & hematology at the University of Nebraska Medical Center, discusses the importance of conducting genetic testing on all patients with diffuse large B-cell lymphoma (DLBCL) to better understand their disease and treat the disease properly.